Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management

Background: Circulating tumor DNA (ctDNA) in the blood plasma of cancer patients is an emerging biomarker used across oncology, facilitating noninvasive disease monitoring and genetic profiling at various disease milestones. Digital droplet PCR (ddPCR) technologies have demonstrated high sensitivity...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diagnostics (Basel)
Main Authors: Wehrle, Julius, Philipp, Ulrike, Jolic, Martina, Follo, Marie, Hussung, Saskia, Waldeck, Silvia, Deuter, Max, Rassner, Michael, Braune, Jan, Rawluk, Justyna, Greil, Christine, Waller, Cornelius F., Becker, Heiko, Duque-Afonso, Jesús, Illert, Anna L., Fritsch, Ralph M., Meiss, Frank, Duyster, Justus, von Bubnoff, Nikolas, Scherer, Florian
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7459590/
https://ncbi.nlm.nih.gov/pubmed/32748806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10080550
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados